Clinical Curative Observation of Using Qingfei Jiedu Decoction Combined with Ambroxol Hydrochloride Tablets in the Treatment of Bronchiectasis at Stable Stage

Ya-qin CHAI,Fang-hong ZHU
2017-01-01
Abstract:Objective:To observe the clinical efficacy of Qingfei Jiedu Decoction combined with Ambroxol Hydrochloride Tablets in the treatment of bronchiectasis.Methods:97cases of bronchiectasis patients in our department of respiration were randomly divided into 2groups,47cases in the controlled group,50cases in the observation group.The patients in the controlled group were treated with Ambroxol Hydrochloride Tablets combined with Salbutamol Aerosol,and 1 courses were taken in January.6courses were taken continuously.Patients in the observation group were treated with Qingfei Jiedu Decoction combined with Ambroxol Hydrochloride Tablets,and 1 courses were taken in January.6courses were taken continuously.The lung function index,blood gas analysis index,total sputum volume of 24hours,the number of exacerbations in 6months,the quality of life score and the clinical efficacy were compared between the 2groups before and after treatment.Results:After treatment,the observation group of patients with the lung function index was significantly higher in patients (P<0.05);2groups of PaO2,SaO2 and PaO2/Fi02 were significantly higher than before treatment (P<0.05),PaCO2 was significantly lower than before treatment (P<0.05),and the observation group was more obviously than the controlled group (P<0.05),the 2group patients after 24hours of total sputum within 6months,the times of acute exacerbation were significantly decreased (P<0.05);and 24hours after treatment in the observation group,sputum volume was significantly lower than the controlled group (P<0.05),acute exacerbation the number was significantly less than the controlled group (P<0.05).The improvement of BODE index and clinical efficacy in the observation group were better than those in the controlled group (P<0.05).Conclusion:Qingfei Jiedu Decoction combined with Ambroxol Hydrochloride Tablets in the treatment of bronchiectasis has good clinical efficacy and is worthy of clinical promotion.
What problem does this paper attempt to address?